Prostate Cancer Completed Phase 2 Trials for Dasatinib (DB01254)

Also known as: Prostatic Cancer / Prostatic neoplasms malignant / Carcinoma Prostate / Cancer Of Prostate / Malignant Neoplasm of Prostate / Prostate Cancers / Prostate carcinoma / Carcinoma of the prostate / Cancer, Prostate / Carcinoma of prostate / Prostatic carcinoma / Carcinoma prostatic / Ca prostate / Prostate cancer NOS

IndicationStatusPhase
DBCOND0062462 (Prostate Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00570700Trial of Dasatinib (Sprycel®) in Subjects With Hormone-refractory Prostate CancerTreatment
NCT00385580Phase II Study of Dasatinib (BMS-354825) for Androgen-deprived Progressive Prostate CancerTreatment